{"id":7455,"date":"2019-06-26T00:00:00","date_gmt":"2019-06-25T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2019\/06\/26\/tractivus-capta-431-000-euros-i-consolida-el-seu-creixement\/"},"modified":"2020-08-07T10:41:20","modified_gmt":"2020-08-07T08:41:20","slug":"tractivus-capta-431-000-euros-i-consolida-el-seu-creixement","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2019\/06\/tractivus-capta-431-000-euros-i-consolida-el-seu-creixement\/","title":{"rendered":"Tractivus capta 431.000 euros i consolida el seu creixement"},"content":{"rendered":"

Tractivus, l’spin-off nascuda de la col\u00b7laboraci\u00f3 entre IDIBELL i el Grup d’Enginyeria de Materials (GEMAT) d’IQS, consolida el seu creixement i l’aven\u00e7 de la seva tecnologia. La companyia, que desenvolupa dispositius m\u00e8dics implantables que eviten la colonitzaci\u00f3 bacteriana, ha tancat molt recentment la seva segona ronda de finan\u00e7ament a trav\u00e9s de la plataforma de crowdfunding Capital Cell, amb la qual ha captat al voltant de 431.000 euros. El capital s’invertir\u00e0 en la millora seu producte i en la preparaci\u00f3 per a iniciar proves cl\u00edniques.<\/p>\n

Tractivus treballa, des del seu naixement el 2015, en la creaci\u00f3 d’un sistema d’autoprotecci\u00f3 consistent en un recobriment de la superf\u00edcie de cada dispositiu m\u00e8dic, que evita l\u2019adhesi\u00f3 de bacteris i la colonitzaci\u00f3 per part d\u2019aquests microorganismes pat\u00f2gens. L’abs\u00e8ncia de colonitzaci\u00f3 i de formaci\u00f3 de biopel\u00b7l\u00edcules augmenta la vida \u00fatil del dispositiu, i evita problemes posteriors a la implantaci\u00f3 i els conseq\u00fcents efectes adversos per al pacient. A m\u00e9s, aquest fet comporta una reducci\u00f3 en els costos de salut directament relacionats amb el tractament de problemes derivats dels implants, com les infeccions i el seu tractament amb antibi\u00f2tics.<\/p>\n

La soluci\u00f3 desenvolupada per Tractivus ha estat batejada com el nom de PHOBOSTechTM. La tecnolog\u00eda, que s’ha validat i patentat, ja t\u00e9 entre els seus productes un stent traqueal i un cat\u00e8ter urinari, que compten amb propietats antibacterianes i s’adapten completament al pacient. La companyia confia en iniciar properament les proves de validaci\u00f3 precl\u00ednica i realitzar un estudi cl\u00ednic entre 2021 i 2022, moment en el qual preveu obrir una tercera ronda de finan\u00e7ament, que complementar\u00e0 i servir\u00e0 de pont d’aquesta segona, i amb la qual espera captar entre dos i tres milions d’euros.<\/p>\n

Les infeccions dels productes sorgides despr\u00e9s de la implantaci\u00f3 \u00e9s un problema que apareix en aproximadament 3,5 milions dels casos entre Europa i els Estats Units anualment, i que significa un sobrecost anual de 45 bilions de d\u00f2lars, aix\u00ed com una taxa de mortalitat d\u2019unes 147.000 persones a l’any.<\/p>\n","protected":false},"excerpt":{"rendered":"

La companyia iniciar\u00e0 properament les proves de validaci\u00f3 precl\u00ednica dels seus dispositius m\u00e8dics implantables<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[493,334],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-05 10:53:40","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7455"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=7455"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7455\/revisions"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=7455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=7455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=7455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}